Mekha Grace Varghese
Mekha Grace Varghese has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Nebu George Thomas
Pushpagiri Institute of Medical Sciences and Research Centre, Pushpagiri Medical Society, Tiruvalla 689101, Kerala, India; Pushpagiri College of Dental Sciences, Medicity, Tiruvalla, Kerala, India; Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, RJ, Brazil
3 shared publications - Aby Mathew T1 shared publication
- Aji P. Mathew
Division of Materials and Environmental Chemistry, Stockholm University, Svante Arrhenius väg 16 C, Stockholm SE-10691, Sweden
1 shared publication - Annie Thomas1 shared publication
Anoop Chandran
St Cyril’s College
1 shared publicationBinsi Puthanpurakkalkizhakkethil Kamalamma
Fish Processing Division, Central Institute of Fisheries Technology, Cochin, India
1 shared publication
Latest Publications
- 30 January 2026
- Published by SAGE Publications in Journal of Biomaterials Applications
Development and evaluation of a fish skin-derived acellular dermal matrix for diabetic wound healing: In vitro and in vivo assessment
Introduction: Non-healing diabetic foot ulcers often result in amputation and reduced quality of life. The study objective was to develop and evaluate a novel fish skin-derived acellular dermal matrix (FSADM) for diabetic wound-healing applications, addressing these challenges. Methods: FSADM was fabricated from yellow fin tuna ( Thunnus albacares ) skin using a decellularization and lyophilization process. The matrix was characterized by Fourier-transform infrared spectroscopy (FTIR). In vitro biocompatibility was assessed using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assays with L929 fibroblasts and hemocompatibility tests. In vivo , biocompatibility was evaluated through subcutaneous implantation in Sprague-Dawley rats. Wound-healing efficacy was assessed in a streptozotocin-induced diabetic rat model with full-thickness excisional wounds, comparing FSADM with commercial alternatives and untreated controls. Results: FTIR analysis confirmed the preservation of collagen structure in FSADM. In vitro studies demonstrated cytocompatibility with L929 cells and minimal haemolytic activity (0.68 ± 0.034%). Subcutaneous implantation demonstrated good biocompatibility, with a progressive reduction in the inflammatory response. In the diabetic wound model, FSADM-treated wounds exhibited significantly faster closure rates than commercial controls ( p < 0.05), achieving 100% closure by day 21, compared to 90% closure in commercial controls. Histological analysis revealed enhanced epithelialization, hair follicle formation, and angiogenesis in FSADM-treated wounds. Conclusion: FSADM demonstrates excellent biocompatibility and superior wound-healing in diabetic conditions compared to commercial alternatives. It presents a promising, sustainable biomaterial for diabetic wound care. Further studies are needed to validate these findings in clinical settings and optimize their therapeutic potential.
- 30 January 2026
- Published by SAGE Publications in Journal of Biomaterials Applications
Development and evaluation of a fish skin-derived acellular dermal matrix for diabetic wound healing: In vitro and in vivo assessment
Introduction: Non-healing diabetic foot ulcers often result in amputation and reduced quality of life. The study objective was to develop and evaluate a novel fish skin-derived acellular dermal matrix (FSADM) for diabetic wound-healing applications, addressing these challenges. Methods: FSADM was fabricated from yellow fin tuna ( Thunnus albacares ) skin using a decellularization and lyophilization process. The matrix was characterized by Fourier-transform infrared spectroscopy (FTIR). In vitro biocompatibility was assessed using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assays with L929 fibroblasts and hemocompatibility tests. In vivo , biocompatibility was evaluated through subcutaneous implantation in Sprague-Dawley rats. Wound-healing efficacy was assessed in a streptozotocin-induced diabetic rat model with full-thickness excisional wounds, comparing FSADM with commercial alternatives and untreated controls. Results: FTIR analysis confirmed the preservation of collagen structure in FSADM. In vitro studies demonstrated cytocompatibility with L929 cells and minimal haemolytic activity (0.68 ± 0.034%). Subcutaneous implantation demonstrated good biocompatibility, with a progressive reduction in the inflammatory response. In the diabetic wound model, FSADM-treated wounds exhibited significantly faster closure rates than commercial controls ( p < 0.05), achieving 100% closure by day 21, compared to 90% closure in commercial controls. Histological analysis revealed enhanced epithelialization, hair follicle formation, and angiogenesis in FSADM-treated wounds. Conclusion: FSADM demonstrates excellent biocompatibility and superior wound-healing in diabetic conditions compared to commercial alternatives. It presents a promising, sustainable biomaterial for diabetic wound care. Further studies are needed to validate these findings in clinical settings and optimize their therapeutic potential.
- Open Access
- 5 June 2024
- Published by IntechOpen
Fabrication Techniques for Scaffolds Applied in Regenerative Medicine
Tissue engineering strategies in regenerative medicine combine cells, scaffolds, and growth factors to regenerate and reconstruct pathologically damaged tissues such as periodontium, bone, nerves, cartilage skin, heart valves, and various other organs. Scaffolds have a major role as they provide a three-dimensional environment for tissue regeneration. They act as an extracellular matrix that favors the ingrowth of new cells thereby assisting the regeneration of target tissues. Various properties of scaffolds like scaffold architecture, surface topography, biodegradability, mechanical properties, and manufacturing process are important to achieve optimal results in tissue engineering. Scaffold fabrication can be achieved by conventional as well as non-conventional current manufacturing techniques. Solvent casting, phase separation, particulate-leaching, gas foaming, freeze-drying, and electrospinning are conventional methods for fabricating scaffolds. The architecture of these scaffolds greatly depends on processing techniques. Fused deposition modeling, hydrogel processing, selective laser sintering, decellularization techniques, three dimensional printing, and bioprinting, are current techniques for scaffold fabrication. The chapter will give an overview of each fabrication technique and will aid biomedical engineers to select the ideal fabrication technique for specific applications in the field of regenerative medicine.
- 5 June 2024
- Published by IntechOpen
Open AccessFabrication Techniques for Scaffolds Applied in Regenerative Medicine
Tissue engineering strategies in regenerative medicine combine cells, scaffolds, and growth factors to regenerate and reconstruct pathologically damaged tissues such as periodontium, bone, nerves, cartilage skin, heart valves, and various other organs. Scaffolds have a major role as they provide a three-dimensional environment for tissue regeneration. They act as an extracellular matrix that favors the ingrowth of new cells thereby assisting the regeneration of target tissues. Various properties of scaffolds like scaffold architecture, surface topography, biodegradability, mechanical properties, and manufacturing process are important to achieve optimal results in tissue engineering. Scaffold fabrication can be achieved by conventional as well as non-conventional current manufacturing techniques. Solvent casting, phase separation, particulate-leaching, gas foaming, freeze-drying, and electrospinning are conventional methods for fabricating scaffolds. The architecture of these scaffolds greatly depends on processing techniques. Fused deposition modeling, hydrogel processing, selective laser sintering, decellularization techniques, three dimensional printing, and bioprinting, are current techniques for scaffold fabrication. The chapter will give an overview of each fabrication technique and will aid biomedical engineers to select the ideal fabrication technique for specific applications in the field of regenerative medicine.
- Open Access
The Design of 3D-Printed Polylactic Acid–Bioglass Composite Scaffold: A Potential Implant Material for Bone Tissue Engineering
Bio-based and patient-specific three-dimensional (3D) scaffolds can present next generation strategies for bone tissue engineering (BTE) to treat critical bone size defects. In the present study, a composite filament of poly lactic acid (PLA) and 45S5 bioglass (BG) were used to 3D print scaffolds intended for bone tissue regeneration. The thermally induced phase separation (TIPS) technique was used to produce composite spheres that were extruded into a continuous filament to 3D print a variety of composite scaffolds. These scaffolds were analyzed for their macro- and microstructures, mechanical properties, in vitro cytotoxicity and in vivo biocompatibility. The results show that the BG particles were homogeneously distributed within the PLA matrix and contributed to an 80% increase in the mechanical strength of the scaffolds. The in vitro cytotoxicity analysis of PLA-BG scaffolds using L929 mouse fibroblast cells confirmed their biocompatibility. During the in vivo studies, the population of the cells showed an elevated level of macrophages and active fibroblasts that are involved in collagen extracellular matrix synthesis. This study demonstrates successful processing of PLA-BG 3D-printed composite scaffolds and their potential as an implant material with a tunable pore structure and mechanical properties for regenerative bone tissue engineering.
Open AccessThe Design of 3D-Printed Polylactic Acid–Bioglass Composite Scaffold: A Potential Implant Material for Bone Tissue Engineering
Bio-based and patient-specific three-dimensional (3D) scaffolds can present next generation strategies for bone tissue engineering (BTE) to treat critical bone size defects. In the present study, a composite filament of poly lactic acid (PLA) and 45S5 bioglass (BG) were used to 3D print scaffolds intended for bone tissue regeneration. The thermally induced phase separation (TIPS) technique was used to produce composite spheres that were extruded into a continuous filament to 3D print a variety of composite scaffolds. These scaffolds were analyzed for their macro- and microstructures, mechanical properties, in vitro cytotoxicity and in vivo biocompatibility. The results show that the BG particles were homogeneously distributed within the PLA matrix and contributed to an 80% increase in the mechanical strength of the scaffolds. The in vitro cytotoxicity analysis of PLA-BG scaffolds using L929 mouse fibroblast cells confirmed their biocompatibility. During the in vivo studies, the population of the cells showed an elevated level of macrophages and active fibroblasts that are involved in collagen extracellular matrix synthesis. This study demonstrates successful processing of PLA-BG 3D-printed composite scaffolds and their potential as an implant material with a tunable pore structure and mechanical properties for regenerative bone tissue engineering.